Heinrich Worth
Overview
Explore the profile of Heinrich Worth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1064
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Criee C, Smith H, Preisser A, Bosch D, Butt U, Borst M, et al.
Pneumologie
. 2024 Nov;
78(12):1003-1013.
PMID: 39547698
During the annual conference of the German Respiratory Society (DGP = Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin) in 2024, updated recommendations for lung function testing have been published. The original...
2.
3.
Lommatzsch M, Criee C, de Jong C, Gappa M, Gessner C, Gerstlauer M, et al.
Pneumologie
. 2024 Mar;
77(8):e3.
PMID: 38513695
No abstract available.
4.
Lommatzsch M, Criee C, de Jong C, Gappa M, Gessner C, Gerstlauer M, et al.
Pneumologie
. 2023 Jul;
77(8):461-543.
PMID: 37406667
The management of asthma has fundamentally changed during the past decades. The present guideline for the diagnosis and treatment of asthma was developed for respiratory specialists who need detailed and...
5.
6.
Andreas S, Kotz D, Batra A, Hellmann A, Muhlig S, Nowak D, et al.
Pneumologie
. 2023 Mar;
77(4):206-219.
PMID: 36958341
Tobacco dependence is a common comorbidity in patients with COPD (Chronic Obstructive Pulmonary Disease) that negatively affects the course of the disease. However, clinically relevant improvement in COPD can only...
7.
Worth H, Buhl R, Criee C, Kardos P, Guckel E, Vogelmeier C
Respir Res
. 2023 Jan;
24(1):2.
PMID: 36604646
Introduction: There is an interest in the role of blood eosinophils for predicting inhaled corticosteroid (ICS) response in chronic obstructive pulmonary disease (COPD). Most data are from interventional clinical studies;...
8.
Gottlieb J, Worth H, Volk T, Fuhner T
Dtsch Arztebl Int
. 2022 Sep;
119(25):438.
PMID: 36178312
No abstract available.
9.
Vogelmeier C, Worth H, Buhl R, Criee C, Guckel E, Kardos P
Respir Res
. 2022 May;
23(1):109.
PMID: 35501806
Introduction: Chronic obstructive pulmonary disease (COPD) guidelines recommend reserving triple therapy of inhaled corticosteroid (ICS), long-acting β-agonist (LABA) and long-acting muscarinic antagonist (LAMA) for patients with exacerbations despite dual therapy....
10.
Bhutani M, Price D, Winders T, Worth H, Gruffydd-Jones K, Tal-Singer R, et al.
Adv Ther
. 2022 Apr;
39(6):2302-2322.
PMID: 35482251
Introduction: Despite being a leading cause of death worldwide, chronic obstructive pulmonary disease (COPD) is underdiagnosed and underprioritized within healthcare systems. Existing healthcare policies should be revisited to include COPD...